UPDATE: JPMorgan Downgrades Terns Pharmaceuticals (TERN) to Neutral
Tweet Send to a Friend
(Updated - March 23, 2022 6:04 AM EDT)
JPMorgan analyst Eric Joseph downgraded Terns Pharmaceuticals (NASDAQ: TERN) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Eric Joseph downgraded Terns Pharmaceuticals (NASDAQ: TERN) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
